Skip to main content
NIH funding notice RFA-DK-22-023

Ancillary Studies to the NIDDK Inflammatory Bowel Disease Genetics Consortium (R01 Clinical Trial Not Allowed)

Closed on November 8, 2023.

Posted
December 23, 2022
Close date
November 8, 2023
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
8
8 new
Median first-year cost
$437,020
$3,295,826 in all
Institutions
8
8 contact PIs

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. BAYLOR COLLEGE OF MEDICINE1
  2. BENAROYA RESEARCH INST AT VIRGINIA MASON1
  3. SINAI HEALTH SYSTEM1
  4. STANFORD UNIVERSITY1
  5. UNIV OF NORTH CAROLINA CHAPEL HILL1

and 3 other institutions

Most frequent study sections

  1. Special Emphasis Panel (ZDK1 GRB-C (M1))4
  2. Special Emphasis Panel (ZDK1 GRB-C (O1))4
8 awards under RFA-DK-22-023 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2024Genetic variants guiding pathogenicity of colitogenic T cells1R01DK140972-01Harrison, Oliver JamesRay, John PhilipBENAROYA RESEARCH INST AT VIRGINIA MASON, WAFirst-year cost $498,064Study section ZDK1
FY2024Trans-ancestry, single-cell multiomics dissection of IBD-associated loci in CD4 memory T cells1R01DK138458-01Chen, WeiDuerr, Richard HUNIVERSITY OF PITTSBURGH AT PITTSBURGH, PAFirst-year cost $477,000Study section ZDK1
FY2024Multi-omic characterization of genetic variants in IBD risk loci1R01DK138462-01Furey, Terrence S.Sheikh, Shehzad Z.UNIV OF NORTH CAROLINA CHAPEL HILL, NCFirst-year cost $459,943Study section ZDK1
FY2024Targeted Identification of IBD Risk Gene Variant Impact on Immune-Epithelial Crosstalk and Intestinal Barrier Function1R01DK138456-01McCole, DeclanUNIVERSITY OF CALIFORNIA RIVERSIDE, CAFirst-year cost $444,809Study section ZDK1
FY2024Impaired cellular RNA editing as a cause of inflammation in inflammatory bowel disease1R01DK140912-01Kuo, Calvin JLi, Jin BillySTANFORD UNIVERSITY, CAFirst-year cost $429,230Study section ZDK1
FY2024Macrophage LRRK2 activity regulates gut epithelial homeostasis1R01DK138465-01A1Liu, Ta-ChiangWASHINGTON UNIVERSITY, MOFirst-year cost $429,180Study section ZDK1
FY2024Understanding the Interaction between Host Genetics, Immune response, and Gut Microbes in Post-operative Recurrence of Crohn's disease1R01DK138466-01Lee, Sun-HoSINAI HEALTH SYSTEM, ONFirst-year cost $324,000Study section ZDK1
FY2024High-throughput functional analyses of the genetic drivers of Inflammatory Bowel Disease1R01DK140907-01Blutt, Sarah ESamuel, Buck SparrowBAYLOR COLLEGE OF MEDICINE, TXFirst-year cost $233,600Study section ZDK1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-16-0.3.5. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.

RFA-DK-22-023: Ancillary Studies to the NIDDK Inflammatory Bowel Disease Genetics Consortium (R01 Clinical Trial Not Allowed) | ScienceDex